I migliori medici per il trattamento di Metaplasia gastrica - TOP-50 medici

Autore di oltre 40 pubblicazioni sottoposte a revisione paritaria in biologia/immunologia dei tumori e terapie sistemiche (immuno- e terapie mirate), membro dell'Associazione Turca di Oncologia Medica e della European Head & Neck Society.

Perché i pazienti scelgono il dott. Bülent Karagoz:

• Trattamenti secondo i protocolli americani nell'ambito della collaborazione strategica della clinica Anadolu con il centro medico leader negli Stati Uniti— Johns Hopkins Medicine.
• Oltre 40 pubblicazioni scientifiche su biologia/immunologia dei tumori e terapie sistemiche (immuno- e terapie mirate).
• Ex direttore di sezione (GATA) e professore/capo dipartimento (Okan, Turchia) — esperienza gestionale e clinica a livello di grandi centri.
• Cura tumori solidi (ad esempio, tumore al seno, ai polmoni, colorettale) utilizzando schemi di trattamento moderni, basandosi sulla biologia del tumore.
• La clinica Anadolu è certificata ESMO e accreditata JCI — il che significa che il dottore tratta secondo protocolli internazionali, all'interno di un team multidisciplinare e sotto rigoroso controllo di sicurezza.

Specializzato in tumori gastrointestinali presso l'Hisar Hospital Intercontinental – formazione di fellowship presso l'Hacettepe University Cancer Institute.

• Si occupa di casi complessi, inclusa la metaplasia gastrica
• Residenza presso l'Istanbul Sisli Etfal Training and Research Hospital
• Formazione aggiuntiva presso l'University of Texas MD Anderson Cancer Center

Il Prof. Kivanc Derya Peker ha eseguito oltre 400 interventi chirurgici per il cancro pancreatico e gastrico, combinando competenza chirurgica con una profonda comprensione della biologia cellulare.

• Ha completato una formazione avanzata presso la Mayo Clinic in Chirurgia Epatopancreatobiliare
• Fondatore dell'unità di Chirurgia Epatopancreatobiliare presso l'Ospedale Dr. Sadi Konuk
• Specializzato in interventi chirurgici per il cancro del pancreas, del fegato e dello stomaco
• Possiede un dottorato in Biologia Medica con focus su invecchiamento e cellule staminali

Assoc. Prof. Dr. Abdulcabbar Kartal is a distinguished colorectal and general surgeon practicing at Anadolu Medical Center in Istanbul. With over 17 years of surgical experience, he specializes in colorectal surgery, HIPEC (hyperthermic intraperitoneal chemotherapy) for peritoneal cancers, bariatric surgery, and minimally invasive procedures.

Dr. Kartal graduated from Istanbul University Faculty of Medicine in 2007 and completed his general surgery specialization at Istanbul Şişli Etfal Training and Research Hospital (2007-2013). He served as Assistant Professor at Istanbul Okan University (2016-2020) before receiving his Associate Professor title in 2020. In 2021, he earned the prestigious FEBS-C certification from the European Society of Coloproctology and became a Fellow of the American College of Surgeons (FACS).

Dr. Kartal has published over 40 articles in international peer-reviewed journals and is an active member of the Turkish Society of Colon and Rectal Surgery, European Society of Coloproctology, and Turkish Surgical Association.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

La Dottoressa Sharon Pelles è un'oncologa altamente rispettata, specializzata nella chirurgia del cancro allo stomaco presso il Sourasky Medical Center (Ichilov).

• Ha condotto ricerche cliniche innovative sugli atteggiamenti dei pazienti oncologici nei confronti delle sperimentazioni
• Esegue procedure avanzate come la HIPEC e l'intervento di Whipple
• Abile nei trattamenti oncologici sia chirurgici che non chirurgici

Doctor Brenda Pastrana is a mexican surgical Oncologist. 

Medical background.

Centro Medico Nacional 20 de Noviembre Issste, Surgical Oncologist in 2020.

Title by Universidad Autónoma de México UNAM.

Surgical Residency Instituto Mexicano del Seguro Social. 2015.

Title by Universidad de Quintana Roo. 

Board Certified by Conacem from 2020 to 2025 number 2171 

Board Certified by Conacem from 2025 to 2030 number 2171

Member of SMEO. Sociedad Mexicana de Oncología. 

University teacher at Universidad Anahuac of Medicine since 2020.

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Head of Teaching at the Puerto Vallarta Regional Hospital

2020-2023

Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020

General practitioner in private medical office

2015-2022

Doctor in charge of weight control clinic

2013-2014

Medical assistant in dermatology clinic

2008-2013

Medical Assistant in Dermatological procedures.

 Medical Assistant in minimally invasive surgical procedures

 Operation of fractional laser machine - IPIXEL-ER and

facial rejuvenation with IPL.

 Experience in laser hair removal with Intense Pulsed Light and

radiofrequency

 Experience with ultrasonic cavitation

 Experience with ultraviolet (UV) light phototherapy machine for the

treatment of psoriasis and vitiligo.

 Experience assisting in Botox and Fillers procedures.

 Biomagnet certified by the Higher Institute of Biomagnetism

doctor ISAAC GOIZ DURAN

 Experience in clinical records

 Training in continuing education and professional development of teachers

Il Dr. Tvaruzek ha eseguito oltre 3.500 interventi chirurgici robotici, inclusi procedure complesse come la prostatectomia con preservazione della funzione erettile.

• Principale esperto certificato da Intuitive Surgical per i robot Da Vinci
• Dirige il Centro di Chirurgia Robotica presso l'Ospedale di St. Zdislava
• Specializzato in chirurgia transorale minimamente invasiva e in chirurgia bariatrica

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Personal information

Title: Professor Doctor

Branch: Radiation Oncology

Work History:

1 GATA Military Medical Faculty

2 Gayrettepe Florence Nightingale Hospital

3 T.R. Demiroğlu Bilim University \ Associate Professor

4 T.R Demiroğlu Bilim University \ Professor

Medical Specialties and Subspecialties:

1 Head and Neck Cancers

2 Radiation Oncology

Priority treatments:

1 Prostate cancer

2 Conformal treatments

Special advanced health technologies:

1 Truebeam Stx Technology

2 Halcyons

Education

1991 - Istanbul University Istanbul Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation

Oncology Specialization Training

La Prof.ssa Yesim Yildirim è una professoressa di oncologia medica specializzata nei tumori gastrointestinali, incluse le condizioni gastriche. Lavora presso l'Anadolu Medical Center.

• Oltre 13 anni all'Anadolu, concentrandosi su immunoterapia e terapie mirate
• Autrice di oltre 80 pubblicazioni internazionali e capitoli di libri medici
• Ha completato la formazione avanzata in oncologia presso cliniche in Israele e nel Regno Unito
• Membro della European Society of Medical Oncology (ESMO)
• Possiede un MBA in Healthcare Management presso la Bilgi University

Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.

La Prof.ssa Elke Jaeger è un'importante specialista in sarcomi ed è considerata uno dei migliori oncologi tedeschi secondo la classifica di Focus.

• Responsabile del dipartimento di Oncologia ed Ematologia presso la Nordwest Klinik
• Oltre 35 anni di esperienza nella pratica oncologica
• Esperienza in ematologia e casi complessi di cancro

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Dr. Saban Sec is a medical oncologist with experience at leading hospitals, including Haseki Training and Research Hospital, Prof. Dr. Cemil Taşcıoğlu City Hospital, and Bahçelievler Medikalpark Hospital. He currently represents specialist physicians in the Turkish Medical Oncology Association. He is also a member of the Istanbul Medical Chamber and the Turkish Medical Oncology Association.

Dr. Sec treats breast, lung, gastrointestinal, prostate, urogenital, head and neck cancers, as well as sarcomas and rare tumors. He has published many peer-reviewed articles on cancer prognosis, treatment outcomes, and survival rates. His research includes studies with large patient groups, such as 138 patients with HER2-positive metastatic gastric cancer. Dr. Sec focuses on prognostic factors and treatment responses in different cancers. He is dedicated to improving cancer care.